<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9915779" created="27/05/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9915779</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="Other">Anoxia/reoxygenation</term>-induced <term id="A2" sem="Other">tolerance</term> with respect to <term id="T1" lex="polymorphonuclear_leukocyte_adhesion" sem="Other"><term id="A3" sem="Cell_natural">polymorphonuclear leukocyte</term> adhesion</term> to <term id="T2" lex="cultured_endothelial_cell" sem="Cell_cultured">cultured endothelial cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="A2"/>
<cause idref="A1"/>
<clue>Anoxia/reoxygenation-<clueType>induced</clueType> tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Cell_adhesion"/>
<theme idref="A3"/>
<theme idref="T2"/>
<clue>Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte <clueType>adhesion</clueType> <linkTheme>to</linkTheme> cultured endothelial cells.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Correlation"/>
<theme idref="E1"/>
<theme idref="E2"/>
<clue>Anoxia/reoxygenation-induced tolerance <linkTheme>with respect to</linkTheme> polymorphonuclear leukocyte adhesion to cultured endothelial cells.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S2">A <term id="T3" lex="nuclear_factor-kappaB-mediated_phenomenon" sem="Other"><term id="T4" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term>-mediated phenomenon</term>.</sentence>
<event KT="Investigation" id="E4">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T4"/>
<clue>A nuclear factor-kappaB-<clueType>mediated</clueType> phenomenon.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">Exposing <term id="T5" lex="human_umbilical_vein_endothelial_cell" sem="Cell_cultured">human umbilical vein endothelial cells</term> (<term id="T6" lex="HUVEC" sem="Cell_cultured">HUVECs</term>) to <term id="T7" lex="anoxia/reoxygenation" sem="Other">anoxia/reoxygenation</term> (<term id="T8" lex="A/R" sem="Other">A/R</term>) results in an increase in <term id="T9" lex="polymorphonuclear_leukocyte_(PMN)_adhesion" sem="Other">polymorphonuclear leukocyte (<term id="T10" lex="PMN" sem="Cell_natural">PMN</term>) adhesion</term> to <term id="T11" lex="HUVEC" sem="Cell_cultured">HUVECs</term>.</sentence>
<event KT="Method" id="E5">
<type class="Artificial_process"/>
<theme idref="T6"/>
<theme idref="T8"/>
<clue><clueType>Exposing</clueType> human umbilical vein endothelial cells (HUVECs) <linkTheme>to</linkTheme> anoxia/reoxygenation (A/R) results in an increase in polymorphonuclear leukocyte (PMN) adhesion to HUVECs.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="E5"/>
<clue>Exposing human umbilical vein endothelial cells (HUVECs) to anoxia/reoxygenation (A/R) <clueType>results in an increase</clueType> <linkTheme>in</linkTheme> polymorphonuclear leukocyte (PMN) adhesion to HUVECs.</clue>
</event>
<event KT="Other" id="E7">
<type class="Cell_adhesion"/>
<theme idref="T10"/>
<theme idref="T11"/>
<clue>Exposing human umbilical vein endothelial cells (HUVECs) to anoxia/reoxygenation (A/R) results in an increase in polymorphonuclear leukocyte (PMN) <clueType>adhesion</clueType> <linkTheme>to</linkTheme> HUVECs.</clue>
</event>
<sentence id="S4">This <term id="T12" lex="A/R" sem="Other">A/R</term>-induced <term id="A13" sem="Other">hyperadhesion</term> is completely prevented by a previous (24 hours earlier) exposure of <term id="T13" lex="HUVEC" sem="Cell_cultured">HUVECs</term> to <term id="T14" lex="A/R" sem="Other">A/R</term>.</sentence>
<event KT="Other" id="E57">
<type class="Positive_regulation"/>
<theme idref="A13"/>
<cause idref="T12"/>
<clue>This A/R-<clueType>induced</clueType> hyperadhesion is completely prevented by a previous (24 hours earlier) exposure of HUVECs to A/R.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Negative_regulation"/>
<theme idref="A13"/>
<cause idref="E9"/>
<clue>This A/R-induced hyperadhesion is completely <clueType>prevented</clueType> <linkCause>by</linkCause> a previous (24 hours earlier) exposure of HUVECs to A/R.</clue>
</event>
<event KT="Other" id="E9">
<type class="Physiological_process"/>
<theme idref="T13"/>
<cause idref="T14"/>
<clue>This A/R-induced hyperadhesion is completely prevented by a <clueTime>previous (24 hours earlier)</clueTime> <clueType>exposure</clueType> <linkTheme>of</linkTheme> HUVECs <linkCause>to</linkCause> A/R.</clue>
</event>
<sentence id="S5">This phenomenon has been termed &quot;<term id="T15" lex="A/R_tolerance" sem="Other"><term id="T16" lex="A/R" sem="Other">A/R</term> tolerance</term>.&quot;</sentence>
<sentence id="S6">Exposing <term id="T17" lex="HUVEC" sem="Cell_cultured">HUVECs</term> to <term id="T18" lex="A/R" sem="Other">A/R</term> induces an increase in <term id="T19" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T20" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>) in <term id="T21" lex="HUVEC_nuclei" sem="Cell_component">HUVEC nuclei</term> within 4 hours.</sentence>
<event KT="Method" id="E10">
<type class="Artificial_process"/>
<theme idref="T17"/>
<theme idref="T18"/>
<clue><clueType>Exposing</clueType> HUVECs <linkTheme>to</linkTheme> A/R induces an increase in nuclear factor kappaB (NF-kappaB) in HUVEC nuclei within 4 hours.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<cause idref="E10"/>
<clue>Exposing HUVECs to A/R <clueType>induces an increase</clueType> <linkTheme>in</linkTheme> nuclear factor kappaB (NF-kappaB) <clueLoc>in HUVEC nuclei</clueLoc> <clueTime>within 4 hours</clueTime>.</clue>
</event>
<sentence id="S7">Interfering with either <term id="T22" lex="NF-kappaB_activation" sem="Other"><term id="T23" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> (<term id="T24" lex="proteasome_inhibitor" sem="Other"><term id="T25" lex="proteasome" sem="Protein_complex">proteasome</term> inhibitor</term>) or translocation (<term id="T26" lex="double-stranded_oligonucleotide" sem="Polynucleotide">double-stranded oligonucleotides</term> containing <term id="T27" lex="NF-kappaB_binding_sequence" sem="DNA_domain_or_region"><term id="T28" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding sequence</term>) prevents the development of <term id="T29" lex="A/R_tolerance" sem="Other"><term id="T30" lex="A/R" sem="Other">A/R</term> tolerance</term> (ie, the increase in <term id="T32" lex="A/R" sem="Other">A/R</term>-induced <term id="T33" lex="PMN_adhesion" sem="Other"><term id="A5" sem="Cell_natural">PMN</term> adhesion</term> to <term id="T34" lex="HUVEC" sem="Cell_cultured">HUVECs</term> is the same after the first and second <term id="T35" lex="A/R_challenge" sem="Other"><term id="T36" lex="A/R" sem="Other">A/R</term> challenges</term>).</sentence>
<event id="E12">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="T24"/>
<clue><clueType>Interfering</clueType> <linkTheme>with</linkTheme> either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E13">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="T27"/>
<clue><clueType>Interfering</clueType> <linkTheme>with</linkTheme> either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="T23"/>
<clue>Interfering with either NF-kappaB <clueType>activation</clueType> (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E15">
<type class="Localization"/>
<theme idref="T23"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or <clueType>translocation</clueType> (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="E12"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) <clueType>prevents</clueType> the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="E13"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) <clueType>prevents</clueType> the development of A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event KT="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the <clueType>development</clueType> <linkTheme>of</linkTheme> A/R tolerance (ie, the increase in A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the <clueType>increase</clueType> <linkTheme>in</linkTheme> A/R-induced PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E20">
<type class="Cell_adhesion"/>
<theme idref="A5"/>
<theme idref="T34"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-induced PMN <clueType>adhesion</clueType> <linkTheme>to</linkTheme> HUVECs is the same after the first and second A/R challenges).</clue>
</event>
<event id="E21">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T32"/>
<clue>Interfering with either NF-kappaB activation (proteasome inhibitor) or translocation (double-stranded oligonucleotides containing NF-kappaB binding sequence) prevents the development of A/R tolerance (ie, the increase in A/R-<clueType>induced</clueType> PMN adhesion to HUVECs is the same after the first and second A/R challenges).</clue>
<comment>NER: T31 del &quot;A/R-induced PMN adhesion&quot;</comment></event>
<sentence id="S8"><term id="A6" lex="NO" sem="Inorganic_compound">NO</term> production by <term id="T37" lex="HUVEC" sem="Cell_cultured">HUVECs</term> is increased after the second <term id="T38" lex="A/R" sem="Other">A/R</term> challenge, but not after the first <term id="T39" lex="A/R_challenge" sem="Other"><term id="T40" lex="A/R" sem="Other">A/R</term> challenge</term>.</sentence>
<event id="E22">
<type class="Metabolism"/>
<theme idref="A6"/>
<clue>NO <clueType>production</clueType> <clueLoc>by HUVECs</clueLoc> is increased after the second A/R challenge, but not after the first A/R challenge.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T40"/>
<cause idref="T38"/>
<clue>NO production by HUVECs is <clueType>increased</clueType> <linkCause>after</linkCause> the second A/R challenge, but not after the first A/R challenge.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Positive_regulation"/>
<theme idref="E22"/>
<cause idref="T40"/>
<clue>NO production by HUVECs is <clueType>increased</clueType> after the second A/R challenge, but <cluePolarity>not</cluePolarity> <linkCause>after</linkCause> the first A/R challenge.</clue>
</event>
<sentence id="S9">Inhibition of <term id="T41" lex="NO_synthase" sem="Protein_molecule">NO synthase</term> (<term id="T42" lex="NOS" sem="Protein_molecule">NOS</term>) during the second <term id="T43" lex="A/R_challenge" sem="Other"><term id="T44" lex="A/R" sem="Other">A/R</term> challenge</term> prevents the development of <term id="A7" sem="Other"><term id="T45" lex="A/R" sem="Other">A/R</term> tolerance</term> with respect to <term id="T46" lex="PMN_adhesion" sem="Other"><term id="A11" sem="Cell_natural">PMN</term> adhesion</term>.</sentence>
<event id="E56">
<type class="Negative_regulation"/>
<theme idref="T42"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NO synthase (NOS) <clueTime>during the second A/R challenge</clueTime> prevents the development of A/R tolerance with respect to PMN adhesion.</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<cause idref="E56"/>
<clue>Inhibition of NO synthase (NOS) during the second A/R challenge <clueType>prevents</clueType> the development of A/R tolerance with respect to PMN adhesion.</clue>
</event>
<event KT="Other" id="E26">
<type class="Positive_regulation"/>
<theme idref="A7"/>
<clue>Inhibition of NO synthase (NOS) during the second A/R challenge prevents the <clueType>development</clueType> <linkTheme>of</linkTheme> A/R tolerance with respect to PMN adhesion.</clue>
</event>
<event KT="Other" id="E27">
<type class="Correlation"/>
<theme idref="E26"/>
<theme idref="E28"/>
<clue>Inhibition of NO synthase (NOS) during the second A/R challenge prevents the development of A/R tolerance <linkTheme>with respect to</linkTheme> PMN adhesion.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E28">
<type class="Cell_adhesion"/>
<theme idref="A11"/>
<clue>Inhibition of NO synthase (NOS) during the second A/R challenge prevents the development of A/R tolerance with respect to PMN <clueType>adhesion</clueType>.</clue>
</event>
<sentence id="S10">However, while <term id="T47" lex="HUVEC" sem="Cell_cultured">HUVECs</term> contained endothelial <term id="T48" lex="NOS_protein" sem="Protein_molecule">NOS protein</term>, no inducible <term id="T49" lex="NOS" sem="Protein_molecule">NOS</term> was detected in either tolerant or <term id="T50" lex="nontolerant_cell" sem="Cell_natural">nontolerant cells</term>.</sentence>
<event id="E29">
<type class="Gene_expression"/>
<theme idref="T28"/>
<clue>However, while <clueLoc>HUVECs</clueLoc> <clueType>contained</clueType> <clueLoc>endothelial</clueLoc> NOS protein, no inducible NOS was detected in either tolerant or nontolerant cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Positive_regulation"/>
<theme idref="T49"/>
<clue>However, while HUVECs contained endothelial NOS protein, <cluePolarity>no</cluePolarity> <clueType>inducible</clueType> NOS was <clueKT>detected</clueKT> <clueLoc>in either tolerant or nontolerant cells</clueLoc>.</clue>
</event>
<sentence id="S11">Further studies indicated that inhibition of <term id="T51" lex="GTP-cyclohydrolase_I" sem="Protein_molecule">GTP-cyclohydrolase I</term> (an enzyme involved in de novo synthesis of an important cofactor for <term id="T52" lex="NOS_activity" sem="Other"><term id="T53" lex="NOS" sem="Protein_molecule">NOS</term> activity</term>, <term id="A12" lex="tetrahydrobiopterin" sem="Organic_compound_other">tetrahydrobiopterin</term>) prevented the generation of <term id="T54" lex="NO" sem="Inorganic_compound">NO</term> in <term id="T55" lex="A/R-tolerant_cell" sem="Cell_cultured"><term id="T56" lex="A/R" sem="Other">A/R</term>-tolerant cells</term>.</sentence>
<event KT="Other" id="E31">
<type class="Negative_regulation"/>
<theme idref="T51"/>
<clue>Further studies indicated that <clueType>inhibition</clueType> <linkTheme>of</linkTheme> GTP-cyclohydrolase I (an enzyme involved in de novo synthesis of an important cofactor for NOS activity, tetrahydrobiopterin) prevented the generation of NO in A/R-tolerant cells.</clue>
</event>
<event KT="Fact" id="E32">
<type class="Regulation"/>
<theme idref="E33"/>
<cause idref="T51"/>
<clue>Further studies indicated that inhibition of GTP-cyclohydrolase I (an enzyme <clueType>involved</clueType> <linkTheme>in</linkTheme> de novo synthesis of an important cofactor for NOS activity, tetrahydrobiopterin) prevented the generation of NO in A/R-tolerant cells.</clue>
</event>
<event KT="Other" id="E33">
<type class="Metabolism"/>
<theme idref="A12"/>
<clue>Further studies indicated that inhibition of GTP-cyclohydrolase I (an enzyme involved in de novo <clueType>synthesis</clueType> <linkTheme>of</linkTheme> an important <corefTheme>cofactor for NOS activity</corefTheme>, tetrahydrobiopterin) prevented the generation of NO in A/R-tolerant cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<cause idref="E31"/>
<clue>Further studies <clueKT><clueCL>indicated</clueCL></clueKT> that inhibition of GTP-cyclohydrolase I (an enzyme involved in de novo synthesis of an important cofactor for NOS activity, tetrahydrobiopterin) <clueType>prevented</clueType> the generation of NO in A/R-tolerant cells.</clue>
</event>
<event KT="Other" id="E35">
<type class="Metabolism"/>
<theme idref="T54"/>
<clue>Further studies indicated that inhibition of GTP-cyclohydrolase I (an enzyme involved in de novo synthesis of an important cofactor for NOS activity, tetrahydrobiopterin) prevented the <clueType>generation</clueType> <linkTheme>of</linkTheme> NO <clueLoc>in A/R-tolerant cells</clueLoc>.</clue>
</event>
<sentence id="S12">Extracellular generation of <term id="T57" lex="NO" sem="Inorganic_compound">NO</term> (<term id="T58" lex="NO" sem="Inorganic_compound">NO</term> donor) did not effect the <term id="A8" sem="Other">hyperadhesion</term> response induced by the initial <term id="T59" lex="A/R_challenge" sem="Other"><term id="T60" lex="A/R" sem="Other">A/R</term> challenge</term>.</sentence>
<event id="E36">
<type class="Metabolism"/>
<theme idref="T57"/>
<clue><clueLoc>Extracellular</clueLoc> <clueType>generation</clueType> <linkTheme>of</linkTheme> NO (NO donor) did not effect the hyperadhesion response induced by the initial A/R challenge.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E37">
<type class="Regulation"/>
<theme idref="E38"/>
<cause idref="E36"/>
<clue>Extracellular generation of NO (NO donor) did <cluePolarity>not</cluePolarity> <clueType>effect</clueType> the hyperadhesion response induced by the initial A/R challenge.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="T60"/>
<clue>Extracellular generation of NO (NO donor) did not effect the hyperadhesion response <clueType>induced</clueType> <linkCause>by</linkCause> the <clueTime>initial</clueTime> A/R challenge.</clue>
</event>
<sentence id="S13"><term id="T61" lex="A/R" sem="Other">A/R</term> also induced an <term id="A9" sem="Other">oxidant stress</term> in naive <term id="T62" lex="HUVEC" sem="Cell_cultured">HUVECs</term>, but not in <term id="T63" lex="A/R-tolerant_HUVEC" sem="Cell_cultured"><term id="T64" lex="A/R" sem="Other">A/R</term>-tolerant <term id="T65" lex="HUVEC" sem="Cell_cultured">HUVECs</term></term>.</sentence>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="T61"/>
<clue>A/R also <clueType>induced</clueType> an oxidant stress <clueLoc>in naive HUVECs</clueLoc>, but not in A/R-tolerant HUVECs.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E40">
<type class="Positive_regulation"/>
<theme idref="A9"/>
<cause idref="T61"/>
<clue>A/R also <clueType>induced</clueType> an oxidant stress in naive HUVECs, but <cluePolarity>not</cluePolarity> <clueLoc>in A/R-tolerant HUVECs</clueLoc>.</clue>
</event>
<sentence id="S14">Inhibition of <term id="T66" lex="NOS" sem="Protein_molecule">NOS</term> during the second <term id="T67" lex="A/R" sem="Other">A/R</term> insult results in the generation of an <term id="T68" lex="oxidant_stress" sem="Other">oxidant stress</term> similar to that observed after the first <term id="T69" lex="A/R_challenge" sem="Other"><term id="T70" lex="A/R" sem="Other">A/R</term> challenge</term>.</sentence>
<event id="E41">
<type class="Negative_regulation"/>
<theme idref="T66"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NOS <clueTime>during the second A/R insult</clueTime> results in the generation of an oxidant stress similar to that observed after the first A/R challenge.</clue>
</event>
<event id="E42">
<type class="Positive_regulation"/>
<theme idref="T68"/>
<cause idref="E41"/>
<clue>Inhibition of NOS during the second A/R insult <clueType>results in the generation</clueType> <linkTheme>of</linkTheme> an oxidant stress similar to that observed after the first A/R challenge.</clue>
</event>
<event id="E43">
<type class="Positive_regulation"/>
<theme idref="T68"/>
<cause idref="T70"/>
<clue>Inhibition of NOS during the second A/R insult results in the generation of an oxidant stress similar to <corefTheme>that</corefTheme> <clueType><clueKT>observed</clueKT></clueType> <linkCause>after</linkCause> the first A/R challenge.</clue>
</event>
<sentence id="S15">Taken together, the findings of the present study are consistent with a role for <term id="T71" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in the development of <term id="T72" lex="A/R_tolerance" sem="Other"><term id="T73" lex="A/R" sem="Other">A/R</term> tolerance</term> (with respect to <term id="T74" lex="PMN_adhesion" sem="Other"><term id="T75" lex="PMN" sem="Cell_natural">PMN</term> adhesion</term>), perhaps by transcriptional regulation of <term id="T76" lex="GTP-cyclohydrolase" sem="Protein_molecule"><term id="T77" lex="GTP" sem="Nucleotide">GTP</term>-cyclohydrolase</term>.</sentence>
<event KT="Analysis" id="E44">
<type class="Regulation"/>
<theme idref="E45"/>
<cause idref="T71"/>
<clue>Taken together, the findings of the present study are consistent with a <clueType><clueKT>role</clueKT></clueType> <linkCause>for</linkCause> NF-kappaB <linkTheme>in</linkTheme> the development of A/R tolerance (with respect to PMN adhesion), perhaps by transcriptional regulation of GTP-cyclohydrolase.</clue>
</event>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="T72"/>
<clue>Taken together, the findings of the present study are consistent with a role for NF-kappaB in the <clueType>development</clueType> <linkTheme>of</linkTheme> A/R tolerance (with respect to PMN adhesion), perhaps by transcriptional regulation of GTP-cyclohydrolase.</clue>
</event>
<event KT="Other" id="E46">
<type class="Correlation"/>
<theme idref="E45"/>
<theme idref="E47"/>
<clue>Taken together, the findings of the present study are consistent with a role for NF-kappaB in the development of A/R tolerance (<clueType>with respect</clueType> <linkTheme>to</linkTheme> PMN adhesion), perhaps by transcriptional regulation of GTP-cyclohydrolase.</clue>
</event>
<event KT="Other" id="E47">
<type class="Cell_adhesion"/>
<theme idref="T75"/>
<clue>Taken together, the findings of the present study are consistent with a role for NF-kappaB in the development of A/R tolerance (with respect to PMN <clueType>adhesion</clueType>), perhaps by transcriptional regulation of GTP-cyclohydrolase.</clue>
</event>
<event CL="L1" KT="Analysis" id="E48" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T76"/>
<cause idref="T71"/>
<clue>Taken together, the findings of the present study are consistent with a role for NF-kappaB in the development of A/R tolerance (with respect to PMN adhesion), <clueKT><clueCL>perhaps</clueCL></clueKT> by <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> GTP-cyclohydrolase.</clue>
</event>
<sentence id="S16">The increased <term id="T78" lex="NO" sem="Inorganic_compound">NO</term> production during the second <term id="T79" lex="A/R" sem="Other">A/R</term> insult reduces <term id="T80" lex="PMN_adhesion" sem="Other"><term id="A10" sem="Cell_natural">PMN</term> adhesion</term> most likely by reducing the <term id="T81" lex="intracellular_oxidant_stress" sem="Other">intracellular oxidant stress</term> induced by <term id="T82" lex="A/R" sem="Other">A/R</term>.</sentence>
<event id="E49">
<type class="Metabolism"/>
<theme idref="T78"/>
<clue>The increased NO <clueType>production</clueType> <clueTime>during the second A/R insult</clueTime> reduces PMN adhesion most likely by reducing the intracellular oxidant stress induced by A/R.</clue>
</event>
<event id="E50">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<clue>The <clueType>increased</clueType> NO production during the second A/R insult reduces PMN adhesion most likely by reducing the intracellular oxidant stress induced by A/R.</clue>
</event>
<event id="E51">
<type class="Negative_regulation"/>
<theme idref="E52"/>
<cause idref="E50"/>
<clue>The increased NO production during the second A/R insult <clueType>reduces</clueType> PMN adhesion most likely by reducing the intracellular oxidant stress induced by A/R.</clue>
</event>
<event id="E52">
<type class="Cell_adhesion"/>
<theme idref="A10"/>
<clue>The increased NO production during the second A/R insult reduces PMN <clueType>adhesion</clueType> most likely by reducing the intracellular oxidant stress induced by A/R.</clue>
</event>
<event KT="Other" id="E53" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E54"/>
<cause idref="E50"/>
<clue>The increased NO production during the second A/R insult reduces PMN adhesion most likely by <clueType>reducing</clueType> the intracellular oxidant stress induced by A/R.</clue>
</event>
<event KT="Other" id="E54">
<type class="Positive_regulation"/>
<theme idref="T81"/>
<cause idref="T82"/>
<clue>The increased NO production during the second A/R insult reduces PMN adhesion most likely by reducing the <clueLoc>intracellular</clueLoc> oxidant stress <clueType>induced</clueType> <linkCause>by</linkCause> A/R.</clue>
</event>
<event CL="L2" KT="Analysis" id="E55" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E51"/>
<cause idref="E53"/>
<clue>The increased NO production during the second A/R insult reduces PMN adhesion <clueKT><clueCL>most likely</clueCL></clueKT> <linkCause>by</linkCause> reducing the intracellular oxidant stress induced by A/R.</clue>
<comment>NO CLUETYPE</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
